Raising Health cover image

Raising Health

Adapting Biopharma to AI with Greg Meyers

Apr 2, 2024
Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb, discusses AI's impact on drug discovery with a16z Bio + Health partner Jorge Conde. They explore AI integration strategies, emerging modalities, and tips for startups partnering with biopharma firms.
33:30

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • AI revolutionizes drug discovery in biopharma for better hit rates and targeted approaches.
  • Partnerships are vital for advancing AI applications in biopharma, aiming to optimize drug development processes.

Deep dives

AI's Impact on Drug Discovery

AI is revolutionizing drug discovery and development in biopharma, enabling more efficient and targeted approaches. By incorporating machine learning in predicting chemical reactivity, companies like BMS have seen significant improvements in hit rates and are scaling up these methods. The future holds potential for AI to transform research processes, with scientists possibly relying on predictive models before conducting wet lab experiments.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode